Timber Creek Capital Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.63M | Sell |
62,164
-57
| -0.1% | -$4.25K | 1.18% | 32 |
|
|
2025
Q1 | $4.57M | Sell |
62,221
-54
| -0.1% | -$3.97K | 1.22% | 34 |
|
|
2024
Q4 | $4.08M | Sell |
62,275
-952
| -2% | -$62.4K | 1.18% | 34 |
|
|
2024
Q3 | $4.93M | Buy |
63,227
+453
| +0.7% | +$35.3K | 1.38% | 29 |
|
|
2024
Q2 | $4.9M | Sell |
62,774
-11,933
| -16% | -$931K | 1.48% | 27 |
|
|
2024
Q1 | $5.06M | Sell |
74,707
-6,011
| -7% | -$407K | 1.58% | 23 |
|
|
2023
Q4 | $5.44M | Buy |
80,718
+1,036
| +1% | +$69.8K | 1.85% | 18 |
|
|
2023
Q3 | $5.4M | Sell |
79,682
-1,350
| -2% | -$91.4K | 1.95% | 18 |
|
|
2023
Q2 | $5.8M | Sell |
81,032
-53
| -0.1% | -$3.79K | 2% | 17 |
|
|
2023
Q1 | $5.63M | Sell |
81,085
-95
| -0.1% | -$6.59K | 2.01% | 16 |
|
|
2022
Q4 | $5.5M | Sell |
81,180
-352
| -0.4% | -$23.9K | 2.08% | 16 |
|
|
2022
Q3 | $4.47M | Sell |
81,532
-3,376
| -4% | -$185K | 1.77% | 24 |
|
|
2022
Q2 | $5.61M | Sell |
84,908
-17,067
| -17% | -$1.13M | 1.85% | 20 |
|
|
2022
Q1 | $6.77M | Buy |
101,975
+10,197
| +11% | +$676K | 2.05% | 16 |
|
|
2021
Q4 | $5.35M | Buy |
91,778
+1,655
| +2% | +$96.4K | 1.59% | 28 |
|
|
2021
Q3 | $5.41M | Buy |
90,123
+318
| +0.4% | +$19.1K | 1.72% | 29 |
|
|
2021
Q2 | $5.38M | Buy |
89,805
+13,150
| +17% | +$788K | 1.74% | 29 |
|
|
2021
Q1 | $3.81M | Buy |
76,655
+5,165
| +7% | +$257K | 1.47% | 30 |
|
|
2020
Q4 | $3.57M | Buy |
71,490
+745
| +1% | +$37.2K | 1.59% | 25 |
|
|
2020
Q3 | $3.88M | Buy |
70,745
+450
| +0.6% | +$24.7K | 2.13% | 17 |
|
|
2020
Q2 | $3.72M | Buy |
70,295
+2,285
| +3% | +$121K | 2.33% | 17 |
|
|
2020
Q1 | $3.04M | Buy |
+68,010
| New | +$3.04M | 2.22% | 16 |
|